StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.75−2.70 (-0.49%)

Close on Nov 17, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Chemed's operating income for the twelve months ending Sep 30, 2026 was $370.86M, up 5.5% year over year. For fiscal 2025 it was $338.25M, down 7.7% from the year before. Over ten years it grew 6.3% a year on average. The highest annual figure on record is $389.68M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$338.25M-7.7%
FY2024Dec 31, 2024$366.49M+7.6%
FY2023Dec 31, 2023$340.57M-0.9%
FY2022Dec 31, 2022$343.50M+0.1%
FY2021Dec 31, 2021$343.04M-12.0%
FY2020Dec 31, 2020$389.68M+51.4%
FY2019Dec 31, 2019$257.38M+5.6%
FY2018Dec 31, 2018$243.63M+115.5%
FY2017Dec 31, 2017$113.04M-36.8%
FY2016Dec 31, 2016$178.75M-3.1%
FY2015Dec 31, 2015$184.46M+9.5%
FY2014Dec 31, 2014$168.42M+26.3%
FY2013Dec 31, 2013$133.39M-14.7%
FY2012Dec 31, 2012$156.42M+1.8%
FY2011Dec 31, 2011$153.73M+7.1%
FY2010Dec 31, 2010$143.52M+13.6%
FY2009Dec 31, 2009$126.35M-4.9%
FY2008Dec 31, 2008$132.86M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$96.42M+29.0%
Q2 FY2026Jun 30, 2026$89.20M+31.0%
Q1 FY2026Mar 31, 2026$84.58M-10.7%
Q4 FY2025Dec 31, 2025$100.65M-11.6%
Q3 FY2025Sep 30, 2025$74.75M-18.9%
Q2 FY2025Jun 30, 2025$68.08M-22.7%
Q1 FY2025Mar 31, 2025$94.76M+31.0%
Q4 FY2024Dec 31, 2024$113.88M+2.2%
Q3 FY2024Sep 30, 2024$92.16M+6.1%
Q2 FY2024Jun 30, 2024$88.13M+26.8%
Q1 FY2024Mar 31, 2024$72.33M-0.7%
Q4 FY2023Dec 31, 2023$111.39M+37.0%
Q3 FY2023Sep 30, 2023$86.85M+7.4%
Q2 FY2023Jun 30, 2023$69.51M-24.4%
Q1 FY2023Mar 31, 2023$72.82M-18.5%
Q4 FY2022Dec 31, 2022$81.33M-17.0%
Q3 FY2022Sep 30, 2022$80.86M-12.9%
Q2 FY2022Jun 30, 2022$91.94M+28.2%
Q1 FY2022Mar 31, 2022$89.37M+11.1%
Q4 FY2021Dec 31, 2021$98.03M-31.6%
Q3 FY2021Sep 30, 2021$92.87M+25.0%
Q2 FY2021Jun 30, 2021$71.70M-22.7%
Q1 FY2021Mar 31, 2021$80.44M+1.4%
Q4 FY2020Dec 31, 2020$143.25M+85.0%
Q3 FY2020Sep 30, 2020$74.31M+14.4%
Q2 FY2020Jun 30, 2020$92.76M+41.6%
Q1 FY2020Mar 31, 2020$79.36M+60.4%
Q4 FY2019Dec 31, 2019$77.45M+14.9%
Q3 FY2019Sep 30, 2019$64.93M+5.2%
Q2 FY2019Jun 30, 2019$65.53M+12.7%
Q1 FY2019Mar 31, 2019$49.47M-12.3%
Q4 FY2018Dec 31, 2018$67.38M+19.2%
Q3 FY2018Sep 30, 2018$61.71M+14.3%
Q2 FY2018Jun 30, 2018$58.14M–
Q1 FY2018Mar 31, 2018$56.40M+36.0%
Q4 FY2017Dec 31, 2017$56.53M+6.4%
Q3 FY2017Sep 30, 2017$54.00M–
Q2 FY2017Jun 30, 2017-$38.95M–
Q1 FY2017Mar 31, 2017$41.45M–
Q4 FY2016Dec 31, 2016$53.12M–

More Chemed figures

See a number that looks wrong?